×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

Ranbaxy acquires Bangalore vaccine firm Biovel

Ranbaxy acquires Bangalore vaccine firm Biovel
Comment E-mail Print Share
First Published: Tue, Jan 19 2010. 03 20 PM IST
Updated: Tue, Jan 19 2010. 03 20 PM IST
Mumbai: Indian drugmaker Ranbaxy Laboratories on Tuesday signed an agreement to acquire product rights and manufacturing facility of Bangalore-based Biovel Lifesciences Pvt Ltd, for an undisclosed sum.
Biovel’s development pipeline comprises of vaccines and biotherapeutics, the two companies said in a statement.
“This transaction with Biovel provides us an entry platform to manufacture vaccines as well as biotherapeutics. The vaccine and biotherapeutics business will be an important part of our growth strategy,” Ranbaxy chief executive Atul Sobti said in the statement.
Ranbaxy is majority owned by Japan’s Daiichi Sankyo.
Comment E-mail Print Share
First Published: Tue, Jan 19 2010. 03 20 PM IST